We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BIB market cap is 0. The company's latest EPS is USD 3.5919 and P/E is 16.46.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.16M | 1.42M | 1.13M | 1.37M | 1.19M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -66.4M | 92.15M | 37.95M | -78.19M | 6.65M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 239.33M | 186.03M | 302.01M | 148.57M | 100.22M |
| Total Liabilities | 31.88M | 2.05M | 14.62M | 54.88M | 3.63M |
| Total Equity | 207.45M | 183.98M | 287.39M | 93.69M | 96.59M |
| Market Cap | 0 |
| Price to Earnings Ratio | 16.46 |
| Price to Sales Ratio | 91.93 |
| Price to Cash Ratio | 251.51 |
| Price to Book Ratio | 1.13 |
| Dividend Yield | - |
| Shares Outstanding | 1.85M |
| Average Volume (1 week) | 15.47k |
| Average Volume (1 Month) | 16.57k |
| 52 Week Change | 0.00% |
| 52 Week High | 62.5746 |
| 52 Week Low | 40.10 |
| Spread (Intraday) | 0 (0%) |
| Company Name | ProShares Ultra NASDAQ Biotechnology |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
